by Cal Strode | May 11, 2022
When Signals first burst onto the scene in 2012, the potential of the regenerative medicine industry still hadn’t set in for many. When the Alliance for Regenerative Medicine (ARM) published its first state of the industry report in 2012, the ARM chairman at the time,...
by Sara M. Nolte | Apr 28, 2022
If I were to ask you to think of a genetic disease that should be a priority for gene therapy research, you might say breast cancer, Huntington’s, or cystic fibrosis. And these are all great candidates. But I’d say you’re missing a big one. Sickle cell disease (SCD)...
by Krystal Jacques | Apr 21, 2022
It’s been all over the news for the last two weeks. Diljeet Gill and colleagues at the Babraham Institute in England are investigating a novel way to reverse aging of skin, opening the door to creating a new possible cell therapy. Their work largely originates from...
by Stacey Johnson | Apr 15, 2022
Every day, it seems there is a new podcast vying for our attention. In specific terms, in 2021 there were 850,000 active podcasts with over 48 million total episodes. (Curious for more podcast stats? Check out this blog by Neal Schaffer.) Podcasts are positively...
by Lyla El-Fayomi | Apr 7, 2022
“Regenerative medicine news under the microscope” is a monthly feature highlighting big stories in stem cell research. I will sample the latest and greatest findings in recent press and package them into a single post. This month, I cover an advance in the treatment...
Comments